Nav: Home

Discovery of biomarkers for the prognosis of chronic kidney disease

July 28, 2016

Currently, there is no effective method to predict the prognosis of chronic kidney disease (CKD) patients. Tomonori Kimura and Yoshitaka Isaka, researchers in Department of Nephrology, Osaka University, found that measuring D-amino acids[1], which present only trace in human, provides prognostic information of CKD. The present discovery would facilitate CKD treatment and thus improve the prognosis of CKD, and may also lead to the further discovery of novel therapy. The potential application is not limited to kidney diseases: the disease context ranges to life style-related diseases such as diabetes mellitus and hypertension, as well as lethal diseases including cardiovascular diseases.

Chronic kidney disease (CKD) is a critical health problem. CKD patients are highly-prevalent throughout the world, and the number of end-stage kidney disease (ESKD) patients, who need to receive cost-prohibitive kidney replacement therapy, is increasing year by year. Additionally, the risk of cardiovascular diseases and death increases with the progression of CKD stages. In Japan, the number of ESKD patients receiving kidney replacement therapy is over 320,000, including 30,000 patients who start it every year. Moreover, it was estimated that about 10% of Japanese population have CKD. Thus, it is critical to prevent CKD patients from the progression to ESKD, however, there is no effective methods to predict the progression of CKD.

On the other hand, D-amino acids, the enantiomers[2] of L-amino acids, are increasingly recognized as potential biomarkers in several diseases. Although the amounts of D-amino acids are usually very trace in human and their existence have been overlooked, recent technological advancement enables us to measure D-amino acids simultaneously with high sensitivity at fentomole[3] levels (Figure 2). The research group from Osaka and Kyushu University searched for prognostic biomarkers of CKD through a chiral amino acid metabolic profiling[4].

The research group measured D-amino acids in blood from CKD patients by applying micro-two-dimensional HPLC (2D-HPLC) system[5] developed by Kenji Hamase, Department of Pharmaceutical Science, Kyushu University, and followed their prognoses. 16 out of 21 D-amino acids were detected in blood from CKD patients. Further analyses revealed that D-Serine and D-Asparagine were associated with the progression of CKD (Figure 3); the risk of progression to ESKD was elevated from 2- to 4- fold in those with higher levels of those D-amino acids (Figure 4).

The results of present study will provide the novel method to the clinician which can identify CKD patients at high-risk for progression to ESKD. The information of D-amino acids would enable to select the best treatment for individual person, as well as the discovery of novel therapy. This method is also applicable to such diseases as life style-associated diseases (diabetes mellitus and hypertension) and cardiovascular diseases, as the prognoses of these diseases are strongly influenced by CKD progression.
-end-


Osaka University

Related Chronic Kidney Disease Articles:

Chronic kidney disease epidemic may be result of high heat, toxins
A mysterious epidemic of chronic kidney disease among agricultural workers and manual laborers may be caused by a combination of increasingly hot temperatures, toxins and infections, according to researchers at the University of Colorado Anschutz Medical Campus.
Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.
Men with chronic kidney disease have worse outcomes than women
Researchers at the University of Illinois at Chicago have found that men with chronic kidney disease, or CKD, are more likely to experience disease progression and death when compared with women suffering from the same condition.
Rates of chronic kidney disease, deaths outpace other diseases
An abundance of high-sugar, high-salt foods in many American diets and obesity-related health problems such as diabetes are likely driving an increase in kidney disease cases, including in young adults, according to researchers at Washington University School of Medicine in St.
Revealed: 35 kidney genes linked to chronic kidney disease risk
An international study lead by University of Manchester scientists has discovered the identity of genes that predispose people to chronic kidney disease.
Gout drug may protect against chronic kidney disease
The drug allopurinol used to manage gout may offer protection against the development of kidney disease, according to a new study.
Chronic kidney disease outcomes can be improved by expanding specialist care
Nearly one in seven Americans has chronic kidney disease, and the condition accounts for about 20 percent of the spending by Medicare.
Ovary removal may increase risk of chronic kidney disease
Premenopausal women who have their ovaries surgically removed face an increased risk of developing chronic kidney disease, according to a Mayo Clinic study published on Wednesday, Sept.
Exercise shown to improve symptoms of patients with chronic kidney disease
Leicester's Hospitals and University of Leicester lead research into CKD.
Susceptible genes identified for childhood chronic kidney disease
Childhood nephrotic syndrome is the most frequently occurring chronic kidney disease among children.
More Chronic Kidney Disease News and Chronic Kidney Disease Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.